≡ Menu

Multaq (dronedarone): Drug Safety Communication – Increased Risk of Death or Serious Cardiovascular Events

A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Multaq (dronedarone): Drug Safety Communication – Increased Risk of Death or Serious Cardiovascular Events. According to the Food & Drug Administration FDA’s MedWatch:

UPDATED 12/19/2011. FDA completed safety review, issued new recommendations. Originally posted 07/21/2011

For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Multaq (dronedarone): Drug Safety Communication – Increased Risk of Death or Serious Cardiovascular Events.

To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.

If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.

{ 0 comments… add one }

Leave a Comment